MedPath

A clinical to compare the onset of drug action time of intravenous ketamine (an anesthetic agent) in pediatric patients with or without congenital heart disease.

Phase 4
Conditions
Health Condition 1: I52- Other heart disorders in diseasesclassified elsewhere
Registration Number
CTRI/2023/08/056235
Lead Sponsor
All India Institute of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Pediatric cardiac surgical patients aged less than 6 years with Congenital heart disease.

2.Pediatric surgical patients aged less than 6 years without Congenital heart disease

Exclusion Criteria

Neonates, Emergency surgery,redo surgery,Patient in shock,sepsis or DIC, Patient in congestive heart failure, Renal dysfunction,severe liver disease,Condition affecting basal metabolic rate i.e, febrile illness,hypothyroidism,hyperthyroidism,pheochromocytoma, Patient on mechanical ventilation,Patient with ventricular dysfunction,Patient with valvular and obstructive lesions,Patient with increased Intra cranial tension and increased intra occular tension

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath